Changes in AGXT2 activity can affect several metabolites, such as endogenous methylarginines13, BAIB31, 61, NO13 and lipids9, 62, which are all known to be dysregulated in diabetes. The gene discussed is AGXT2; the disease is diabetes mellitus.